PERSPECTIVE (ASE) THERAPEUTICS financial statements

퍼스펙티브 테라퓨틱스NYSEAMERICAN:CATX · NYSE Amex · Healthcare · sector #16
$2.36-8.17%
2026-10-06 close · prelim

PERSPECTIVE (ASE) THERAPEUTICS's published financial data is dated 2026-10-04. 2024 revenue was $1M. 2024 operating profit was −$91M.

Reported results

PERSPECTIVE (ASE) THERAPEUTICS notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q